UB Ventures

UB Ventures is a VC firm focused on oncology, dedicated to investing in early-stage breakthrough innovations. We empower visionary teams, often serving as the first check, to drive innovation in the field and turning peer-reviewed science into market-ready therapies. UB Ventures is more than a traditional venture fund. We strive to be a true partner rather than just a line item on the cap table by providing a real, tangible value add. Our disciplined investment approach is hence anchored by the following pillars: ▪ Oncology-Focused: We invest in breakthrough innovations that address the most critical challenges in healthcare, with oncology at the heart of our approach. ▪ Pre-Seed/Early Seed Stage Investing: Our focus is on early-stage opportunities with the potential to rapidly evolve into market-leading ventures. We are usually the first check in most of our portfolio companies and we're proud of it. We believe in early conviction and hands-on support. ▪ Team, #1 Criteria: Exceptional leadership is paramount; we prioritize founding teams that exhibit visionary leadership, operational excellence, and robust scientific acumen. ▪ Data Driven: Every investment decision is underpinned by rigorous data analysis and objective evaluation, ensuring that each opportunity is meticulously vetted. ▪ Agile: As a rolling fund, our nimble approach enables us to adapt swiftly to market dynamics and capitalize on emerging opportunities. ▪ Geographic Focus: We exclusively invest in US-based companies, leveraging a market enriched by robust regulatory oversight, deep innovation networks, and dynamic healthcare ecosystems. ▪ Platform Venture Investment Model: Beyond providing capital, we offer comprehensive strategic guidance, operational support, and access to an extensive network of industry experts and partners, cultivating an ecosystem designed to accelerate growth.